Lilly, Novo bet on amylin obesity drugs after GLP-1s

Health

Lilly, Novo Bet On Amylin Obesity Drugs After Glp-1S

By CNBC

The next generation of blockbuster obesity drugs isn't trying to replace GLP-1 medicines. Instead, drugmakers are developing treatments that can complement existing drugs and push weight loss further, or offer new options for potentially millions of ...Read more

Related Posts

Dana White's Latest UFC Prodigy Gets KO'd In 12 Seconds

Dana White's Latest UFC Prodigy Gets KO'd In 12 Seconds

Sep 21, 2026
Colorectal Cancer Is Rising Among Kids and Teens-and It's Not the Same Disease Adults Get

Colorectal Cancer Is Rising Among Kids and Teens-and It's Not the Same Disease Adults Get

Oct 02, 2026
7 Benefits of The Keto Diet

7 Benefits of The Keto Diet

Dec 30, 2020
Ultra-processed foods could harm our health. Here are what nutritionists say to buy instead

Ultra-processed foods could harm our health. Here are what nutritionists say to buy instead

Sep 29, 2026
We use cookies to help provide you with the best experience when you visit our websites. By using this site you consent to the use of cookies on your device. see our cookie policy.